Copyright Reports & Markets. All rights reserved.

Global Fluorescein-NHS Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Fluorescein-NHS Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Mixed Isomer
    • 1.3.3 Fluorescein-PEG-NHS
    • 1.3.4 Carboxyfluorescein
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Fluorescein-NHS Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Protein Labelling & Crosslinking
    • 1.4.3 Fluorescence Microscopy
    • 1.4.4 Flow Cytometry
  • 1.5 Global Fluorescein-NHS Market Size & Forecast
    • 1.5.1 Global Fluorescein-NHS Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Fluorescein-NHS Sales Quantity (2020-2031)
    • 1.5.3 Global Fluorescein-NHS Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher
    • 2.1.1 Thermo Fisher Details
    • 2.1.2 Thermo Fisher Major Business
    • 2.1.3 Thermo Fisher Fluorescein-NHS Product and Services
    • 2.1.4 Thermo Fisher Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Thermo Fisher Recent Developments/Updates
  • 2.2 Sigma-Aldrich
    • 2.2.1 Sigma-Aldrich Details
    • 2.2.2 Sigma-Aldrich Major Business
    • 2.2.3 Sigma-Aldrich Fluorescein-NHS Product and Services
    • 2.2.4 Sigma-Aldrich Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Sigma-Aldrich Recent Developments/Updates
  • 2.3 BroadPharm
    • 2.3.1 BroadPharm Details
    • 2.3.2 BroadPharm Major Business
    • 2.3.3 BroadPharm Fluorescein-NHS Product and Services
    • 2.3.4 BroadPharm Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 BroadPharm Recent Developments/Updates
  • 2.4 MuseChem
    • 2.4.1 MuseChem Details
    • 2.4.2 MuseChem Major Business
    • 2.4.3 MuseChem Fluorescein-NHS Product and Services
    • 2.4.4 MuseChem Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 MuseChem Recent Developments/Updates
  • 2.5 AKos GmbH
    • 2.5.1 AKos GmbH Details
    • 2.5.2 AKos GmbH Major Business
    • 2.5.3 AKos GmbH Fluorescein-NHS Product and Services
    • 2.5.4 AKos GmbH Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 AKos GmbH Recent Developments/Updates
  • 2.6 Lumiprobe
    • 2.6.1 Lumiprobe Details
    • 2.6.2 Lumiprobe Major Business
    • 2.6.3 Lumiprobe Fluorescein-NHS Product and Services
    • 2.6.4 Lumiprobe Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Lumiprobe Recent Developments/Updates
  • 2.7 AHH Chemical co.,lttd
    • 2.7.1 AHH Chemical co.,lttd Details
    • 2.7.2 AHH Chemical co.,lttd Major Business
    • 2.7.3 AHH Chemical co.,lttd Fluorescein-NHS Product and Services
    • 2.7.4 AHH Chemical co.,lttd Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 AHH Chemical co.,lttd Recent Developments/Updates
  • 2.8 Glentham Life Sciences Ltd.
    • 2.8.1 Glentham Life Sciences Ltd. Details
    • 2.8.2 Glentham Life Sciences Ltd. Major Business
    • 2.8.3 Glentham Life Sciences Ltd. Fluorescein-NHS Product and Services
    • 2.8.4 Glentham Life Sciences Ltd. Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Glentham Life Sciences Ltd. Recent Developments/Updates
  • 2.9 Chengdu Biocone Biological Technology Co., Ltd.
    • 2.9.1 Chengdu Biocone Biological Technology Co., Ltd. Details
    • 2.9.2 Chengdu Biocone Biological Technology Co., Ltd. Major Business
    • 2.9.3 Chengdu Biocone Biological Technology Co., Ltd. Fluorescein-NHS Product and Services
    • 2.9.4 Chengdu Biocone Biological Technology Co., Ltd. Fluorescein-NHS Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Chengdu Biocone Biological Technology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Fluorescein-NHS by Manufacturer

  • 3.1 Global Fluorescein-NHS Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Fluorescein-NHS Revenue by Manufacturer (2020-2025)
  • 3.3 Global Fluorescein-NHS Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Fluorescein-NHS by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Fluorescein-NHS Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Fluorescein-NHS Manufacturer Market Share in 2024
  • 3.5 Fluorescein-NHS Market: Overall Company Footprint Analysis
    • 3.5.1 Fluorescein-NHS Market: Region Footprint
    • 3.5.2 Fluorescein-NHS Market: Company Product Type Footprint
    • 3.5.3 Fluorescein-NHS Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Fluorescein-NHS Market Size by Region
    • 4.1.1 Global Fluorescein-NHS Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Fluorescein-NHS Consumption Value by Region (2020-2031)
    • 4.1.3 Global Fluorescein-NHS Average Price by Region (2020-2031)
  • 4.2 North America Fluorescein-NHS Consumption Value (2020-2031)
  • 4.3 Europe Fluorescein-NHS Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Fluorescein-NHS Consumption Value (2020-2031)
  • 4.5 South America Fluorescein-NHS Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Fluorescein-NHS Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 5.2 Global Fluorescein-NHS Consumption Value by Type (2020-2031)
  • 5.3 Global Fluorescein-NHS Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 6.2 Global Fluorescein-NHS Consumption Value by Application (2020-2031)
  • 6.3 Global Fluorescein-NHS Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 7.2 North America Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 7.3 North America Fluorescein-NHS Market Size by Country
    • 7.3.1 North America Fluorescein-NHS Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Fluorescein-NHS Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 8.2 Europe Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 8.3 Europe Fluorescein-NHS Market Size by Country
    • 8.3.1 Europe Fluorescein-NHS Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Fluorescein-NHS Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Fluorescein-NHS Market Size by Region
    • 9.3.1 Asia-Pacific Fluorescein-NHS Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Fluorescein-NHS Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 10.2 South America Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 10.3 South America Fluorescein-NHS Market Size by Country
    • 10.3.1 South America Fluorescein-NHS Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Fluorescein-NHS Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Fluorescein-NHS Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Fluorescein-NHS Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Fluorescein-NHS Market Size by Country
    • 11.3.1 Middle East & Africa Fluorescein-NHS Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Fluorescein-NHS Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Fluorescein-NHS Market Drivers
  • 12.2 Fluorescein-NHS Market Restraints
  • 12.3 Fluorescein-NHS Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Fluorescein-NHS and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Fluorescein-NHS
  • 13.3 Fluorescein-NHS Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Fluorescein-NHS Typical Distributors
  • 14.3 Fluorescein-NHS Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Fluorescein-NHS market size was valued at US$ 214 million in 2024 and is forecast to a readjusted size of USD 332 million by 2031 with a CAGR of 6.5% during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    NHS-Fluorescein is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA. The NHS-ester of fluorescein efficiently labels antibodies and other purified proteins at primary amines (lysine side chains)
    Fluorescein-NHS, also known as fluorescein isothiocyanate (FITC), is a fluorescent dye commonly used in various biological and chemical applications, including molecular biology, cell biology, and immunology. Fluorescein-NHS found extensive use in biotechnology and life sciences research, including fluorescence microscopy, flow cytometry, and protein labeling. Its fluorescent properties make it valuable for visualizing biological structures and molecules. The demand for Fluorescein-NHS was driven by increasing research activities in the fields of molecular biology, immunology, and cell biology. It was also used in diagnostic applications, such as immunoassays and fluorescence-based detection methods.
    This report is a detailed and comprehensive analysis for global Fluorescein-NHS market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Fluorescein-NHS market size and forecasts, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/mg), 2020-2031
    Global Fluorescein-NHS market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/mg), 2020-2031
    Global Fluorescein-NHS market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kilograms), and average selling prices (US$/mg), 2020-2031
    Global Fluorescein-NHS market shares of main players, shipments in revenue ($ Million), sales quantity (Kilograms), and ASP (US$/mg), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Fluorescein-NHS
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Fluorescein-NHS market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Sigma-Aldrich, BroadPharm, MuseChem, AKos GmbH, Lumiprobe, AHH Chemical co.,lttd, Glentham Life Sciences Ltd., Chengdu Biocone Biological Technology Co., Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Fluorescein-NHS market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Mixed Isomer
    Fluorescein-PEG-NHS
    Carboxyfluorescein
    Market segment by Application
    Protein Labelling & Crosslinking
    Fluorescence Microscopy
    Flow Cytometry
    Major players covered
    Thermo Fisher
    Sigma-Aldrich
    BroadPharm
    MuseChem
    AKos GmbH
    Lumiprobe
    AHH Chemical co.,lttd
    Glentham Life Sciences Ltd.
    Chengdu Biocone Biological Technology Co., Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Fluorescein-NHS product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Fluorescein-NHS, with price, sales quantity, revenue, and global market share of Fluorescein-NHS from 2020 to 2025.
    Chapter 3, the Fluorescein-NHS competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Fluorescein-NHS breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fluorescein-NHS market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Fluorescein-NHS.
    Chapter 14 and 15, to describe Fluorescein-NHS sales channel, distributors, customers, research findings and conclusion.

    Buy now